Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01753830 · ClinicalTrials.gov registry record · NA
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
A NA study, sponsored by Galderma R&D.
- Terminated
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT01753830 is a NA study that was terminated before completion, run by Galderma R&D. The registered enrollment target is 75 participants.
The verdict
NCT01753830, a NA study, was terminated before completion, sponsored by Galderma R&D.
- TERMINATED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.
Interventions
- DEVICE PBS
- DEVICE Durolane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01753830
The ClinicalTrials.gov registry entry for NCT01753830 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PBS is the first listed.
NCT01753830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01753830 about?
NCT01753830 is a clinical study titled "Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis". The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.
What is the current status of trial NCT01753830?
This trial is currently terminated. It is a NA study. The enrollment target is 75 participants. The study started on 2012-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01753830?
The interventions under investigation include: PBS (DEVICE), Durolane (DEVICE).
Who is sponsoring clinical trial NCT01753830?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.